RXRX

Biotech Beast Biotechnology RXRX Uncategorized

Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead

Mar 2, 2026

Biotechnology Edmund Ingham RXRX Uncategorized

Recursion Pharmaceuticals Q4: Why My December Buy Call Was Too Optimistic

Feb 25, 2026

Biotechnology RHHBF RHHBY RXRX Uncategorized

Recursion jumps after solid Q4 beat

Feb 25, 2026

APLD Biotechnology CRWV INTC NOK NVDA RXRX SNPS Uncategorized

Recursion Pharmaceuticals and Applied Digital shares fall after Nvidia exits stakes

Feb 18, 2026

openai-considers-backing-ai-led-drug-discovery-firms:-report

ABCL ABSI Biotechnology CSCO GOOG GOOGL JNJ OPENAI PFE RXRX SDGR Uncategorized

OpenAI considers backing AI-led drug discovery firms: report

Feb 3, 2026

Comments (8) Luis Alvarez/DigitalVision via Getty Images OpenAI (OPENAI) CEO Sam Altman said his startup...

Biotechnology MIRM NBIX RXRX TAK Uncategorized XOMA

Takeda, XOMA ink new royalty agreement; amend existing deal

Dec 30, 2025

recursion-jumps-as-jp.-morgan-upgrades-on-lead-program

Biotechnology RXRX Uncategorized

Recursion jumps as J.P. Morgan upgrades on lead program

Dec 17, 2025

Douglas Rissing Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P....

Biotechnology RXRX Uncategorized

Recursion rises on new data for asset for polyps

Dec 8, 2025